VANGUARD GROUP INC 13D and 13G filings for Inovio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:06 pm Purchase | 2023-12-29 | 13G | Inovio Pharmaceuticals, Inc. INO | VANGUARD GROUP INC | 19,766,042 7.240% | 18,345,834 (+1291.77%) | Filing |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | Inovio Pharmaceuticals, Inc. INO | VANGUARD GROUP INC | 1,420,208 6.830% | 500,266 (+54.38%) | Filing |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | VANGUARD GROUP INC | 919,943 5.250% | 154,473 (+20.18%) | Filing |
| 2021-02-10 11:04 am Purchase | 2020-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | VANGUARD GROUP INC | 765,470 5.420% | 344,437 (+81.81%) | Filing |